Simone Incicco
Assistan Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (15)
Year:
2026
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Background and Aims: Removal/suppression of the primary etiological factor reduces the risk of decompensation and mortality in compensated cirrhosis. However, in decompensated cirrhosis, the impact of etiologic treatment is less predictable. We aimed to evaluate the impact of etiological treatment in patients with cirrhosis who developed ascites as single index decompensating event. Approach and Results: Patients with cirrhosis and ascites as single first decompensation event were included and followed until death, liver transplantation, or Q3/2021. The etiology was considered “cured” (alcohol abstinence, hepatitis C cure, and hepatitis B suppression) versus “controlled” (partial removal of etiologic factors) versus “uncontrolled.” A total of 622 patients were included in the study. Etiology was “cured” in 146 patients (24%), “controlled” in 170 (27%), and “uncontrolled” in 306 (49%). During follow-up, 350 patients (56%) developed further decompensation. In multivariable analysis (adjusted for age, sex, varices, etiology, Child-Pugh class, creatinine, sodium, and era of decompensation), etiological cure was independently associated with a lower risk of further decompensation (HR: 0.46; p = 0.001). During follow-up, 250 patients (40.2%) died, while 104 (16.7%) underwent LT. In multivariable analysis, etiological cure was independently associated with a lower mortality risk (HR: 0.35, p < 0.001). Conclusions: In patients with cirrhosis and ascites as single first decompensating event, the cure of liver disease etiology represents a main treatment goal since this translates into considerably lower risks of further decompensation and mortality.
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Collaborators (23)
Salvatore Piano
University of Padova
Samir Kumar-Singh
Professor of Molecular Pathology
University of Antwerp
Stine Johansen
Medical doctor
Odense University Hospital
Guillem Pera
Statistician
Escola Superior de Ciències de la Salut TecnoCampus
Mads Israelsen
Rigshospitalet
Aleksander Krag
University of Southern Denmark
Harry de Koning
Full professor
Erasmus University Rotterdam
Carmen Expósito
Profesora asociada
Universitat Autònoma de Barcelona (UAB)
Maja Thiele
Odense University Hospital
Judit Pich
Head of the Clinical Trials Unit
Hospital Clínic de Barcelona
Kavish R. Patidar
Houston Methodist
Carmine Gambino
Assistant Professor of Medicine
Azienda Ospedale Università Padova
Cristina Laserna Jiménez
Lecturer
University of Barcelona
Mar Coll Loperena
Tenured Associate Professor
University of Barcelona
Marta Carol
Professora Lectora
University of Barcelona
Rafael Bañares
Full Professor
Universidad Complutense de Madrid
Wim Laleman
MD PhD
-
Patrizia Burra
Vice Rector for Research Training
University of Padova
Nikolaj Christian Torp
University of Southern Denmark
Elisa Pose
University of Barcelona
Roberta Gagliardi
University of Padua
Indra Neil Guha
University of Nottingham
Giacomo Zaccherini
Tenured Assistant Professor of Internal Medicine
University of Bologna
Make your next move.
Prepare your application
Review drafts before you send them.